Global Financial Private Client’s Biogen BIIB Stock Holding History

Global Financial Private Client’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-8	Closed	-$1.09K	–	376
2025 Q1	$1.09K	Buy	8 +3	+60%	+$429	﹤0.01%	1040
2024 Q4	$765	Sell	5 -85	-94%	-$14.3K	﹤0.01%	832
2024 Q3	$17.4K	Hold	90	–	–	0.01%	450
2024 Q2	$20.9K	Hold	90	–	–	0.01%	383
2024 Q1	$19.3K	Hold	90	–	–	0.01%	401
2023 Q4	$23.3K	Sell	90 -1,699	-95%	-$417K	0.01%	377
2023 Q3	$452K	Sell	1,789 -6	-0.3%	-$1.6K	0.23%	101
2023 Q2	$512K	Buy	1,795 +13	+0.7%	+$3.87K	0.25%	96
2023 Q1	$494K	Buy	1,782 +391	+28%	+$108K	0.25%	97
2022 Q4	$385K	Buy	1,391 +27	+2%	+$7.63K	0.22%	100
2022 Q3	$361K	Buy	1,364 +1,362	+68,100%	+$289K	0.21%	106
2022 Q2	$421	Hold	2	–	–	﹤0.01%	620
2022 Q1	$421	Hold	2	–	–	﹤0.01%	635
2021 Q4	$480	Hold	2	–	–	﹤0.01%	623
2021 Q3	$568	Hold	2	–	–	﹤0.01%	569
2021 Q2	$698	Hold	2	–	–	﹤0.01%	564
2021 Q1	$557	Hold	2	–	–	﹤0.01%	547
2020 Q4	$490	Buy	+2	New	+$516	﹤0.01%	534

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Global Financial Private Client's BIIB Position: Q2 2025 in Review

Global Financial Private Client sold out of Biogen (BIIB) in Q2 2025, closing a stake of 8 shares — an estimated $1.09K sold.

Global Financial Private Client first reported a position in BIIB in Q4 2020 and held it in 18 quarters. The position peaked at $512K in Q2 2023. 866 funds tracked by Wall St. Rank hold BIIB as of Q2 2025.

Global Financial Private Client reported no remaining Biogen position as of Q2 2025 after selling out during the quarter.
Global Financial Private Client sold 8 Biogen shares in Q2 2025, an estimated $1.09K.
Global Financial Private Client first reported a position in Biogen in Q4 2020 and held it in 18 quarters.
Global Financial Private Client's Biogen position peaked at $512K in Q2 2023.
866 funds tracked by Wall St. Rank held Biogen as of Q2 2025.

Based on Global Financial Private Client's 13F filing for Q2 2025, filed 10 Jul 2025.